Recent in North America (page 15 of 16)
Mar 31, 2006 | David C. Steinberg, Steinberg & Associates
Methods of registering cosmetic formulations are changing. This column will desribe the online registration processes for the United States and Canada.
Mar 24, 2006
Tony O’Lenick asks: What is the difference between a drug and cosmetic? David Steinberg explains.
Mar 1, 2006
A recent paper calling for further research into the alleged link between aluminium salts in antiperspirants and breast cancer should not constitute alarm, said the CTPA.
Feb 20, 2006
The American Academy of Dermatology (AAD) recently issued a statement in response to the U.S. Food and Drug Administration’s (FDA) decision that a black box warning be added to labels...
Feb 16, 2006
The U.S. Food and Drug Administration (FDA) released a new report that examines the way the agency reviews applications for drugs and biologics that have not previously been approved by the FDA.
Feb 14, 2006
Patient safety while taking isotretinoin depends on the careful oversight of the prescriber, according to the American Academy of Dermatology Association.
Feb 2, 2006 | David C. Steinberg, Steinberg & Associates
California’s Safe Cosmetic Act Well, he did it. In October Governor Arnold Schwarzenegger signed into law the California Safe Cosmetic Act of 2005. As reported in my last column, this new law will not make cosmetics safer than they are now, but will increase costs for cosmetic companies and the taxpayers of the State of California while accomplishing absolutely nothing.
Dec 23, 2005 | David C. Steinberg, Steinberg & Associates
At the December 2003 Society of Cosmetic Chemists annual meeting, I presented a one-day session on international cosmetic regulations, and concluded by saying that 2004 would be the year of Canada. So far in 2004, three major changes have occurred.
Dec 18, 2005 | David C. Steinberg, Steinberg & Associates
On August 26, 2004, the entire cosmetic industry dodged a bullet--or rather, Armageddon–by a single vote. The California Assembly rejected a bill that would have prohibited California companies from making or selling cosmetic/personal care items that contain phthalates and other ingredients considered under this law as toxic. The vote was 4 in favor, 5 opposed and 10 others either abstained or weren’t present.
Dec 18, 2005 | Richard Balano and Lenore Coyle, NOVA Technology Corp.
21 CFR Part 11 specifies the comprehensive set of administrative, procedural and technical controls that must be implemented when data files, records and signatures are created, maintained or archived in an electronic format as part of a program to comply with FDA rules. In the cosmetics industry, specific applications are in development and testing of OTC drugs and color additives.
Dec 13, 2005 | Lawrence Evans III, Ph.D., Stefan Schuber, Ph.D., United States Pharmacopeia
This article gives an overview of the standards-setting process used in the United States Pharmacopeia and National Formulary (USP–NF), an annual publication that helps to ensure the integrity of ingredients used in cosmetics, toiletries and other personal care products.
Dec 13, 2005 | David C. Steinberg, Steinberg & Associates
There have been several important changes from the U.S. Food and Drug Administration (FDA), Japan and the European Union (EU) which will affect cosmetics sold in these countries. The additions in Japan and the safety issues raised by the Scientifi c Committee on Consumer Products (SCCP) in the EU will impact formulators worldwide by permitting once-restricted ingredients, requesting more safety evaluations or changing labeling requirements.